首頁 > 市場調查報告書 > 醫療設備

眼科設備

仿生眼市場規模、佔有率和成長分析（按類型、技術、義眼系統、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902547

仿生眼市場規模、佔有率和成長分析（按類型、技術、義眼系統、最終用戶和地區分類）－2026-2033年產業預測

Bionic Eye Market Size, Share, and Growth Analysis, By Type (External Eye, Implanted Eye), By Technology (Electronic, Mechanical), By Prosthesis System, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，仿生眼市場規模將達到 3.4033 億美元，到 2025 年將成長至 3.8417 億美元，到 2033 年將成長至 10.1265 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.複合年成長率。

受視網膜疾病發生率上升和人口老化的影響，仿生眼市場正經歷強勁成長。這些因素催生了對能夠恢復視力的先進解決方案的巨大需求。仿生眼技術的創新，包括可植入設備和與功能性視網膜細胞相互作用的外部影像處理單元，正在提升視覺能力。持續的研究旨在提高解析度和整體性能，從而改善患者的治療效果。然而，該市場也面臨許多挑戰，例如植入和手術高成本，限制了許多患者（尤其是在發展中地區）的接受度。此外，仿生眼的長期安全性和有效性正受到密切關注，而監管障礙和各地不同的報銷政策也進一步阻礙了市場的普及和成長。

仿生眼市場促進因素

視網膜色素變性和老齡化黃斑部病變等視網膜疾病的日益增加是推動仿生眼市場成長的關鍵因素。隨著越來越多的人因這些視網膜疾病而遭受嚴重的視力障礙甚至失明，人們對旨在恢復視力的創新仿生眼技術的需求也日益成長。這種對有效解決方案的需求推動了仿生眼研發領域的關注和投資，以滿足那些希望恢復視力並提高生活品質的人們的需求。隨著人們對這些疾病的認知不斷提高，視力恢復設備的進步潛力也隨之增強。

限制仿生眼市場的因素

仿生眼市場面臨許多挑戰，其中植入設備的高昂成本以及相關的手術費用尤其突出。這些成本構成了巨大的准入障礙，尤其是在醫療基礎設施落後、保險覆蓋不足的地區。設備帶來的經濟負擔以及保險覆蓋的困難會阻礙仿生眼技術的廣泛應用。因此，價格承受能力問題和有限的保險覆蓋範圍成為市場成長的障礙，影響著人們從仿生眼技術帶來的視力恢復解決方案中獲益的能力。

仿生眼市場趨勢

仿生眼市場正呈現小型化和植入式設計的顯著趨勢，這提高了患者的舒適度和手術可行性。這些進步使得更小巧、更隱密、更易於安裝的設備得以研發，從而改善了患者的整體體驗。此外，具備無線供電和資料傳輸功能的創新植入式仿生眼正日益受到關注，有助於與現有醫療生態系統無縫整合。這種向小型化解決方案的轉變不僅推動了視力恢復技術的進步，也凸顯了醫療設備業日益重視以患者為中心的設計理念，有望擴大市場覆蓋範圍並改善臨床療效。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Second Sight Medical Products, Inc.（USA）
Pixium Vision（France）
Monash Vision Group（Australia）
Nano Retina Ltd.（Israel）
Optobionics Corporation（Japan）
Nidek Co., Ltd.（Japan）
Bionic Vision Technologies（Australia）
iBionics（USA）
Vivani Medical Inc.（USA）
MetaModal LLC（USA）
Biomedical Technologies SL（Spain）

結論與建議

簡介目錄

Product Code: SQMIG35H2113

Bionic Eye Market size was valued at USD 340.33 Million in 2024 and is poised to grow from USD 384.17 Million in 2025 to USD 1012.65 Million by 2033, growing at a CAGR of 12.88% during the forecast period (2026-2033).

The bionic eye market is witnessing robust growth, driven by rising retinal disease prevalence and an aging population. These factors generate substantial demand for advanced solutions capable of restoring vision. Innovations in bionic eye technology, including implantable devices that interact with functional retinal cells and external image processing units, are leading to enhanced visual capabilities. Ongoing research aims to improve resolution and overall performance, contributing to better patient outcomes. However, the market faces challenges such as high costs associated with implants and surgical procedures, limiting access for many, especially in developing regions. Additionally, the long-term safety and efficacy of bionic eyes are under scrutiny, and regulatory hurdles combined with varying reimbursement policies further complicate market adoption and growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bionic Eye market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bionic Eye Market Segments Analysis

Global Bionic Eye Market is segmented by type, technology, end users, prosthesis system and region. Based on type, the market is segmented into external eye and implanted eye. Based on technology, the market is segmented into electronic and mechanical. Based on prosthesis system, the market is segmented into Argus II, Alpha IMS, Alpha AMS, IRIS II, and Others. Based on end users, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bionic Eye Market

The growing prevalence of retinal diseases, including conditions like retinitis pigmentosa and age-related macular degeneration, plays a crucial role in driving the bionic eye market. With an increasing number of people experiencing severe vision impairment or blindness as a result of these retinal disorders, there is an escalating demand for innovative bionic eye technologies aimed at restoring vision. This need for effective solutions enhances interest and investment in bionic eye developments, catering to those seeking to regain their sight and improve their quality of life. As awareness of these conditions rises, so too does the potential for advancements in vision restoration devices.

Restraints in the Bionic Eye Market

The bionic eye market faces significant challenges due to the high costs associated with implants and the surgical procedures required for their installation. These expenses create substantial barriers to accessibility, particularly in areas where healthcare infrastructure is lacking or reimbursement options are inadequate. The financial burden of these devices and the difficulties in obtaining coverage can impede the widespread adoption of bionic eye technology. As a result, affordability issues and limited reimbursement opportunities serve as obstacles to market growth, impacting the potential for individuals to benefit from advancements in vision restoration solutions offered by bionic eye innovations.

Market Trends of the Bionic Eye Market

The bionic eye market is experiencing a notable trend toward miniaturisation and implantable designs, enhancing both patient comfort and surgical feasibility. These advancements enable the development of smaller, more discreet devices that are easier to install, thereby improving the overall patient experience. Additionally, innovative implantable bionic eyes equipped with wireless power and data transmission capabilities are gaining prominence, facilitating seamless integration with existing healthcare ecosystems. This shift towards compact solutions not only supports advancements in vision restoration technologies but also emphasizes the growing focus on patient-centric designs in the medical device industry, potentially expanding market reach and improving clinical outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bionic Eye Market Size by Type & CAGR (2026-2033)

Market Overview
External Eye
Implanted Eye

Global Bionic Eye Market Size by Prosthesis System & CAGR (2026-2033)

Market Overview
Argus II
Alpha IMS
Alpha AMS
IRIS II
Others

Global Bionic Eye Market Size by Technology & CAGR (2026-2033)

Market Overview
Electronic
Mechanical

Global Bionic Eye Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Ophthalmic Clinics
Others

Global Bionic Eye Market Size & CAGR (2026-2033)

North America (Type, Prosthesis System, Technology, End Users)
- US
- Canada
Europe (Type, Prosthesis System, Technology, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Prosthesis System, Technology, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Prosthesis System, Technology, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Prosthesis System, Technology, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Second Sight Medical Products, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pixium Vision (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monash Vision Group (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Retina Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optobionics Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidek Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bionic Vision Technologies (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iBionics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivani Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MetaModal LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomedical Technologies S.L. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments